In May 2024, Reuters reported more optimistic forecasts from other experts with BMO Capital expecting the weight-loss market to reach $150 billion by the early 2030s, while Leerink projects a $158 billion value by 2032
Analysts expect supply constraints to improve but note that the broader issue will take years to resolve
The primary endpoint of resolution of MASH without worsening of fibrosis was achieved in 40%, 36%, 59%, and 17% of participants in the 0.1, 0.2, 0.4 mg, and placebo groups, respectively ( p 90%) were mild to moderate in severity
How Do You Take a BPC 157 Dosage
The mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice
The answer isn't another drug, it's knowing which treatment works for which patient, from day one